Literature DB >> 9266719

Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3.

W K McCoubrey1, T J Huang, M D Maines.   

Abstract

Two isozymes of heme oxygenase (HO), HO-1 or HSP32 and the constitutive form HO-2, have been characterized to date. We report the discovery of a third protein species and refer to it as HO-3. HO-3 is the product of a single transcript of approximately 2.4 kb and can encode a protein of approximately 33 kDa. The HO-3 transcript is found in the spleen, liver, thymus, prostate, heart, kidney, brain and testis and is the product of a single-copy gene. The predicted amino acid structure of HO-3 differs from both HO-1 (HSP32) and HO-2 but is closely related to HO-2 (approximately 90%). Escherichia coli expressed and purified HO-3 protein does not cross react with polyclonal antibodies to either rat HO-1 or HO-2, is a poor heme catalyst, and displays hemoprotein spectral characteristics. The predicted protein has two heme regulatory motifs that may be involved in heme binding. These motifs and the hemoprotein nature of HO-3 suggest a potential regulatory role for the protein in cellular processes which are heme-dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266719     DOI: 10.1111/j.1432-1033.1997.00725.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  132 in total

1.  Heme oxygenase-1 in tissue pathology: the Yin and Yang.

Authors:  Z Dong; Y Lavrovsky; M A Venkatachalam; A K Roy
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Self-cytoprotection against stress: feedback regulation of heme-dependent metabolism.

Authors:  P M Schwartsburd
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

Review 3.  Hypoxia. 3. Hypoxia and neurotransmitter synthesis.

Authors:  Ganesh K Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

4.  Rickettsia rickettsii infection of cultured human endothelial cells induces heme oxygenase 1 expression.

Authors:  Elena Rydkina; Abha Sahni; David J Silverman; Sanjeev K Sahni
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia.

Authors:  Melissa M Singh; Mary E Irwin; Yin Gao; Kechen Ban; Ping Shi; Ralph B Arlinghaus; Hesham M Amin; Joya Chandra
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

6.  Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia.

Authors:  T Minamino; H Christou; C M Hsieh; Y Liu; V Dhawan; N G Abraham; M A Perrella; S A Mitsialis; S Kourembanas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 7.  Toward Carbon Monoxide-Based Therapeutics: Critical Drug Delivery and Developability Issues.

Authors:  Xingyue Ji; Krishna Damera; Yueqin Zheng; Bingchen Yu; Leo E Otterbein; Binghe Wang
Journal:  J Pharm Sci       Date:  2016-01-06       Impact factor: 3.534

Review 8.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 9.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

Review 10.  Metalloporphyrins in the management of neonatal hyperbilirubinemia.

Authors:  David K Stevenson; Ronald J Wong
Journal:  Semin Fetal Neonatal Med       Date:  2009-12-16       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.